YU8402A - Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina - Google Patents

Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina

Info

Publication number
YU8402A
YU8402A YU8402A YUP8402A YU8402A YU 8402 A YU8402 A YU 8402A YU 8402 A YU8402 A YU 8402A YU P8402 A YUP8402 A YU P8402A YU 8402 A YU8402 A YU 8402A
Authority
YU
Yugoslavia
Prior art keywords
ratio
avermectins
streptomyces avermitilis
gene directing
avermitilis
Prior art date
Application number
YU8402A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU8402A publication Critical patent/YU8402A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Ovaj pronalazak se odnosi na polinukleotidne molekule koji sadrže nukleotidne sekvence koje kodiraju produkt aveC gena, gde ti polinukelotidni molekuli mogu biti korišćeni da izmene odnos ili količinu klase 2:1 avermektina proizvedenih u fermentacionim kulturama S. avermitilis Ovaj pronalazak se dalje odnosi na vektore, ćelije domaćine, i mutante sojeve S. avermitilis u kojima je aveC gen inaktiviran, ili mutiran tako da menja odnos ili količinu klase 2:1 proizvedenih avermektina.[The present invention relates to polynucleotide molecules comprising nucleotide sequences encoding an aveC gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of S. avermitilis. The present invention further relates to vectors, host cells, and mutant strains of S. avermitilis in which the aveC gene has been inactivated, or mutated so as to change the ratio or amount of class 2:1 avermectins produced.
YU8402A 1999-08-12 2000-07-19 Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina YU8402A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
YU8402A true YU8402A (sh) 2006-03-03

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
YU8402A YU8402A (sh) 1999-08-12 2000-07-19 Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina

Country Status (37)

Country Link
US (8) US6248579B1 (sh)
EP (1) EP1200605B1 (sh)
JP (2) JP3688640B2 (sh)
KR (1) KR100486006B1 (sh)
CN (1) CN1186447C (sh)
AP (2) AP2002002417A0 (sh)
AR (1) AR021450A1 (sh)
AT (1) ATE283363T1 (sh)
AU (1) AU779756B2 (sh)
BG (1) BG106478A (sh)
BR (1) BR0013093A (sh)
CA (1) CA2381427A1 (sh)
CO (1) CO5290296A1 (sh)
CZ (1) CZ2002297A3 (sh)
DE (1) DE60016231T2 (sh)
EA (1) EA004569B1 (sh)
ES (1) ES2231214T3 (sh)
GT (2) GT200000138CA (sh)
HK (1) HK1046536B (sh)
HR (1) HRP20020131A2 (sh)
HU (1) HUP0202517A2 (sh)
IL (1) IL147562A0 (sh)
IS (1) IS6249A (sh)
MA (1) MA26811A1 (sh)
MX (1) MXPA02001514A (sh)
NO (1) NO20020665D0 (sh)
OA (1) OA11997A (sh)
PA (1) PA8499201A1 (sh)
PE (1) PE20010697A1 (sh)
PL (1) PL353770A1 (sh)
PT (1) PT1200605E (sh)
SK (1) SK1382002A3 (sh)
TN (1) TNSN00170A1 (sh)
UY (1) UY26287A1 (sh)
WO (1) WO2001012822A1 (sh)
YU (1) YU8402A (sh)
ZA (1) ZA200201071B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60031126T2 (de) * 1999-08-12 2007-02-08 Pfizer Products Inc., Groton Streptomyces avermitilis gen zum regulieren des verhältnisses der b2:b1 avermectinen
WO2003065991A2 (en) 2002-02-05 2003-08-14 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
EP1476539B1 (en) 2002-02-12 2009-03-25 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
WO2004067549A2 (de) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
DE3881147T2 (de) 1987-10-23 1993-09-02 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
DE69023036T2 (de) 1989-03-31 1996-06-13 Merck & Co Inc Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
ES2204914T3 (es) 1993-07-30 2004-05-01 Pfizer Inc. Genes que codifican el complejo alfa cetoacido deshidrogenasa de cadena ramificada de streptomyces avermitilis.
KR100186946B1 (ko) * 1993-10-05 1999-04-01 알렌 제이.스피겔 도라멕틴의 구충활성 중간체 및 도라멕틴의 제조방법
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자

Also Published As

Publication number Publication date
KR20020022809A (ko) 2002-03-27
SK1382002A3 (en) 2002-11-06
US6833263B2 (en) 2004-12-21
UY26287A1 (es) 2001-03-16
NO20020665L (no) 2002-02-11
AU5702100A (en) 2001-03-13
US20010016350A1 (en) 2001-08-23
CO5290296A1 (es) 2003-06-27
US6511841B2 (en) 2003-01-28
DE60016231D1 (de) 2004-12-30
AU779756B2 (en) 2005-02-10
TNSN00170A1 (fr) 2005-11-10
US20030124607A1 (en) 2003-07-03
PE20010697A1 (es) 2001-07-05
CA2381427A1 (en) 2001-02-22
IL147562A0 (en) 2002-08-14
BR0013093A (pt) 2002-08-13
GT200000138CA (es) 2002-02-02
US7029887B2 (en) 2006-04-18
MA26811A1 (fr) 2004-12-20
KR100486006B1 (ko) 2005-05-03
CN1186447C (zh) 2005-01-26
PT1200605E (pt) 2005-04-29
US20010024818A1 (en) 2001-09-27
WO2001012822A1 (en) 2001-02-22
AP2002002419A0 (en) 2002-03-31
US20030129635A1 (en) 2003-07-10
US20030134313A1 (en) 2003-07-17
US20050196777A1 (en) 2005-09-08
US7259241B2 (en) 2007-08-21
US6248579B1 (en) 2001-06-19
GT200000138A (es) 2002-02-02
HUP0202517A2 (hu) 2002-11-28
JP2003507018A (ja) 2003-02-25
AP2002002417A0 (en) 2002-03-31
NO20020665D0 (no) 2002-02-11
US20030129636A1 (en) 2003-07-10
EA200200057A1 (ru) 2002-06-27
AR021450A1 (es) 2002-07-17
OA11997A (en) 2006-04-18
EP1200605A1 (en) 2002-05-02
US6509159B2 (en) 2003-01-21
CN1370239A (zh) 2002-09-18
ZA200201071B (en) 2003-06-25
PA8499201A1 (es) 2001-12-14
JP3688640B2 (ja) 2005-08-31
DE60016231T2 (de) 2005-12-08
MXPA02001514A (es) 2002-07-02
CZ2002297A3 (cs) 2002-08-14
EP1200605B1 (en) 2004-11-24
IS6249A (is) 2002-01-25
HK1046536B (zh) 2005-05-13
PL353770A1 (en) 2003-12-01
HK1046536A1 (en) 2003-01-17
BG106478A (bg) 2004-02-27
ES2231214T3 (es) 2005-05-16
EA004569B1 (ru) 2004-06-24
JP2005198658A (ja) 2005-07-28
ATE283363T1 (de) 2004-12-15
HRP20020131A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
BR9712878A (pt) Variante de enzima subtilase, processos para a identificação de uma variante de protease apresentando estabilidade autoproteolìtica e paraq a produção de uma enzima subtilase mutante e de uma variante de subtilase, sequência de dna, vetor, célula hospedeira microbiana, composição e uso de uma variante de subtilase.
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
EP0346000A3 (en) Macrolide biosynthetic genes for use in streptomyces and other organisms
EP1700915A3 (en) Enzymatic DNA molecules
AU1231701A (en) Production of polyketides
Colby et al. Insertional inactivation of the Streptococcus mutans dexA (dextranase) gene results in altered adherence and dextran catabolism
PL343246A1 (en) Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
YU8402A (sh) Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
BG104759A (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
CY1105778T1 (el) Γονιδιο του streptomyces avermitilis που κατευθυνει την αναλογια των αβepμεκτινων β2:β1
RS70004A (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectin
BR0110128A (pt) Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase
WO2000037608A3 (en) Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
WO2002010203A3 (en) Daz genes
WO2004108906A3 (de) Bakterielle träger für nukleotidsequenzen kodierend für wirkstoffe
RO116209B1 (ro) Procedeu de obţinere a hemicelulazelor prin biosinteză bacteriană